Lisa Tracker® monitoring tests to be offered with Biogaran’s biosimilar drugs Croissy-Beaubourg, March 28, 2018, 6:00pm CEST – THERADIAG (ISIN code: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, is today announcing that it…
Croissy-Beaubourg, March 26, 2018, 5:45pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces today its financial reporting schedule for 2018. Financial publications will be released after market…
Lisa Tracker®, the most comprehensive monitoring range on the market covering all gastroenterology patients Croissy-Beaubourg, February 28, 2018, 6:00pm CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER), a company specialising in in vitro diagnostics and theranostics,…